About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04031781

The Role of Left Prefrontal Transcranial Magnetic Stimulation in Episodic Migraine Prophylaxis

The aim of the study was to examine the prophylactic role of repetitive transcranial magnetic stimulation (rTMS) on the frequency, and severity of migraine attacks in episodic migraineurs who failed m...

Lead sponsor: Ain Shams University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Ain Shams University

Age

16 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•cases diagnosed as episodic migraine with or without aura according to the ICHD 3rd edition
•With a headache frequency of 4-14 per month for the last six months
•Patients who had either an unsatisfactory response, declined or were intolerant to at least two prophylactic medications.

Exclusion Criteria

•Patients with past family history of seizures
•Other chronic pain disorders
•Severe depression (Beck Depression Inventory of 30 or more)
•Other significant neurologic or psychiatric diagnosis including substance misuse
•Metal implants in the head
•Pregnant or breastfeeding ladies
•Prior experience with TMS

Related studies

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A

NCT06222697 · Hemophilia A, Prophylaxis of Bleeding, and more

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

RECRUITINGPhase 3

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT07044297 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 24, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment33

Start dateMay 2013

Last updatedJul 24, 2019

Condition

Episodic Migraine Prophylaxis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 24, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions